Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for PAVM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 -2.663M
March 31, 2026 -2.62M
December 31, 2025 -1.551M
September 30, 2025 -0.896M
June 30, 2025 -1.178M
March 31, 2025 -1.581M
December 31, 2024 0.094M
September 30, 2024 -8.883M
June 30, 2024 -11.66M
March 31, 2024 -13.11M
December 31, 2023 -11.87M
September 30, 2023 -11.09M
June 30, 2023 -12.79M
March 31, 2023 -16.29M
December 31, 2022 -16.82M
September 30, 2022 -19.34M
June 30, 2022 -22.56M
March 31, 2022 -12.26M
December 31, 2021 -16.78M
September 30, 2021 -8.018M
June 30, 2021 -6.628M
March 31, 2021 -9.168M
December 31, 2020 -6.728M
Date Value
September 30, 2020 -5.839M
June 30, 2020 -5.556M
March 31, 2020 -3.791M
December 31, 2019 -4.090M
September 30, 2019 -2.878M
June 30, 2019 -2.519M
March 31, 2019 -3.870M
December 31, 2018 -3.019M
September 30, 2018 -1.866M
June 30, 2018 -1.702M
March 31, 2018 -2.200M
December 31, 2017 -1.587M
September 30, 2017 -2.372M
June 30, 2017 -0.8236M
March 31, 2017 -1.825M
December 31, 2016 -1.203M
September 30, 2016 -1.227M
June 30, 2016 -1.506M
March 31, 2016 -0.5187M
December 31, 2015 -0.648M
September 30, 2015 -0.3178M
June 30, 2015 -0.2262M
March 31, 2015 -0.0576M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 2.488B
AngioDynamics, Inc. 17.45M
Alphatec Holdings, Inc. 20.51M
AtriCure, Inc. 22.19M
Baxter International, Inc. 285.00M